Immediate Impact

63 standout
Sub-graph 1 of 23

Citing Papers

Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled release
2024 Standout
Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study
2024 Standout
4 intermediate papers

Works of Arwa Ali being referenced

Survival outcomes of CD34+CD38−LSCs and their expression of CD123 in adult AML patients
2018
Survival of Patients with Non-Small-Cell Lung Cancer after a Diagnosis of Brain Metastases
2013
and 1 more

Author Peers

Author Last Decade Papers Cites
Arwa Ali 295 231 201 31 594
Kaimin Hu 230 333 206 23 721
Małgorzata Nowicka 324 258 331 24 645
Wim Wynendaele 295 302 136 24 683
Emily K. Slotkin 205 215 257 38 520
R. Molife 290 299 276 24 688
Giuliana Restante 313 334 318 25 695
Xinying Su 254 366 228 33 693
A. Van Oosterom 268 237 207 29 576
Katalin Karászi 130 227 113 22 603
Silvia P. Neciosup 393 239 194 45 690

All Works

Loading papers...

Rankless by CCL
2026